• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Align Technology Inc. (Amendment)

    2/14/22 12:32:22 PM ET
    $ALGN
    Industrial Specialties
    Health Care
    Get the next $ALGN alert in real time by email
    SC 13G/A 1 d9252314_13g-a.htm

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, DC 20549

     

    SCHEDULE 13G
    (Rule 13d-102)

     

    INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

    TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED

    PURSUANT TO RULE 13d-2(b)

     

    (Amendment No. 2)*

     

     

    Align Technology, Inc.
    (Name of Issuer)

     

     

     Common Stock, $0.0001 par value
    (Title of Class of Securities)

     

     

    016255101
    (CUSIP Number)

     

     

    December 31, 2021
    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    [X] Rule 13d-1(b)

     

    [_] Rule 13d-1(c)

     

    [_] Rule 13d-1(d)

     

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     
     

     

    CUSIP No. 016255101    

     

         
    1. NAME OF REPORTING PERSONS  
      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)  
         
      Edgewood Management LLC  
         
    2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
        (a)  [_]
        (b)  [X]
         
    3. SEC USE ONLY  
         
         
         
    4. CITIZENSHIP OR PLACE OF ORGANIZATION  
         
      Connecticut  
         
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
         
    5. SOLE VOTING POWER  
         
      4,271,448  
         
    6. SHARED VOTING POWER  
         
      0  
         
    7. SOLE DISPOSITIVE POWER  
         
      4,385,581  
         
    8. SHARED DISPOSITIVE POWER  
         
      0  
         
    9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
         
      4,385,581  
         
    10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)  
        [_]

         
         
    11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)  
         
      5.6%  
         
    12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)  
         
      IA  
         

     

    ____________

    (1)       Edgewood Management LLC may be deemed to be the beneficial owner of such securities by virtue of its role as the investment manager of the investment funds or accounts which own such securities.

     

     
     

     

    CUSIP No. 016255101    

     

    Item 1. (a). Name of Issuer:  
           
        Align Technology, Inc.  

     

      (b). Address of issuer's principal executive offices:  
           
       

    410 North Scottsdale Road, Suite 1300

    Tempe, AZ 85281 

     

     

    Item 2. (a). Name of person filing:  
           
        Edgewood Management LLC  

     

      (b). Address or principal business office or, if none, residence:  
           
       

    600 Steamboat Road, Suite 103

    Greenwich, Connecticut 06830

     

     

      (c). Citizenship:  
           
        Connecticut  

     

      (d). Title of class of securities:  
           
         Common Stock, $0.0001 par value  

     

      (e). CUSIP No.:  
           
        016255101  

     

     
     

     

    Item 3.

    If This Statement is filed pursuant to §§.240.13d-1(b) or 240.13d-2(b), or (c), check whether the person filing is a

     

     

      (a) [_] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
           
      (b) [_] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
           
      (c) [_] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
           
      (d) [_] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
           
      (e) [X] An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
           
      (f) [_] An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
           
      (g) [_] A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
           
      (h) [_] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C.1813);
           
      (i) [_] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
           
      (j) [_] Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
           

     

    Item 4. Ownership.

     

      Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

     

      (a) Amount beneficially owned:
         
        4,385,581

     

      (b) Percent of class:
         
        5.6%

     

      (c)   Number of shares as to which the person has:

     

         
        (i) Sole power to vote or to direct the vote 4,271,448 ,
             
        (ii)   Shared power to vote or to direct the vote 0 ,
             
        (iii) Sole power to dispose or to direct the disposition of 4,385,581   ,
             
        (iv)   Shared power to dispose or to direct the disposition of 0 .
             

     

     
     

     

    Item 5. Ownership of Five Percent or Less of a Class.
     

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ].

     

      N/A
       
    Item 6. Ownership of More Than Five Percent on Behalf of Another Person.
     

    If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.

     

      All of the securities reported in this Schedule 13G are directly owned by advisory clients of Edgewood Management LLC.  None of those advisory clients may be deemed to beneficially own more than 5% of the Common Stock.
       
    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     

    If a parent holding company or control person has filed this schedule, pursuant to Rule 13d-1(b)(1)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company or control person has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.

     

      N/A
       

     

     

     
     

     

    Item 8. Identification and Classification of Members of the Group.
     

    If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identity of each member of the group.

     

      N/A
       
    Item 9. Notice of Dissolution of Group.
     

    Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity. See Item 5.

     

      N/A
       
    Item 10. Certification.

     

        By signing below the Reporting Person certifies that, to the best of his knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

     

     

     
     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

      February 11, 2022
      (Date)
       
       
      Edgewood Management LLC *
       
      By: /s/ Edgewood Management LLC
      Name: Olivia Fleming
      Title: Authorized Person
       

     

     

     

     

     

     

     

     

    Get the next $ALGN alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALGN

    DatePrice TargetRatingAnalyst
    7/31/2025$154.00Overweight → Equal-Weight
    Morgan Stanley
    4/25/2025$170.00Buy → Hold
    HSBC Securities
    2/14/2025$255.00Overweight
    Wells Fargo
    1/6/2025$235.00 → $280.00Market Perform → Outperform
    Leerink Partners
    12/4/2024$295.00Outperform
    Mizuho
    10/10/2024Hold
    Needham
    2/26/2024$310.00Market Perform
    Leerink Partners
    12/11/2023$197.00Neutral → Sell
    Goldman
    More analyst ratings

    $ALGN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Align Tech downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded Align Tech from Overweight to Equal-Weight and set a new price target of $154.00

    7/31/25 7:16:13 AM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Tech downgraded by HSBC Securities with a new price target

    HSBC Securities downgraded Align Tech from Buy to Hold and set a new price target of $170.00

    4/25/25 8:29:20 AM ET
    $ALGN
    Industrial Specialties
    Health Care

    Wells Fargo initiated coverage on Align Tech with a new price target

    Wells Fargo initiated coverage of Align Tech with a rating of Overweight and set a new price target of $255.00

    2/14/25 7:02:00 AM ET
    $ALGN
    Industrial Specialties
    Health Care

    $ALGN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, CHIEF LEGAL & REGULATORY Coletti Julie Ann bought $4,606 worth of shares (42 units at $109.66), increasing direct ownership by 0.59% to 7,110 units (SEC Form 4)

    4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

    8/1/25 5:58:45 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    PRESIDENT AND CEO Hogan Joseph M bought $996,131 worth of shares (7,576 units at $131.49), increasing direct ownership by 4% to 184,945 units (SEC Form 4)

    4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

    8/1/25 4:05:18 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    Director Larkin C Raymond Jr bought $1,529,645 worth of shares (6,500 units at $235.33) and gifted 4,650 shares, increasing direct ownership by 9% to 23,597 units (SEC Form 4)

    4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

    8/19/24 6:35:02 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    $ALGN
    SEC Filings

    View All

    SEC Form S-8 filed by Align Technology Inc.

    S-8 - ALIGN TECHNOLOGY INC (0001097149) (Filer)

    8/6/25 4:27:27 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    SEC Form 10-Q filed by Align Technology Inc.

    10-Q - ALIGN TECHNOLOGY INC (0001097149) (Filer)

    8/6/25 4:07:34 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Technology Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - ALIGN TECHNOLOGY INC (0001097149) (Filer)

    8/4/25 8:32:00 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    $ALGN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, CHIEF LEGAL & REGULATORY Coletti Julie Ann bought $4,606 worth of shares (42 units at $109.66), increasing direct ownership by 0.59% to 7,110 units (SEC Form 4)

    4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

    8/1/25 5:58:45 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    PRESIDENT AND CEO Hogan Joseph M bought $996,131 worth of shares (7,576 units at $131.49), increasing direct ownership by 4% to 184,945 units (SEC Form 4)

    4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

    8/1/25 4:05:18 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    SEC Form 4 filed by Director Vitalone Britt J.

    4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

    7/7/25 4:13:42 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    $ALGN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Align Technology Inc. (Amendment)

    SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)

    2/13/24 4:59:02 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    SEC Form SC 13G/A filed by Align Technology Inc. (Amendment)

    SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)

    2/9/24 4:31:42 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    SEC Form SC 13G/A filed by Align Technology Inc. (Amendment)

    SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)

    2/9/23 11:07:31 AM ET
    $ALGN
    Industrial Specialties
    Health Care

    $ALGN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Align Technology Initiates Patent Infringement Ligitation Against Angelalign Technology

    Enforces patents representing critical components of its broad intellectual property portfolio and reflecting key investments and innovations in clear aligner therapy, including multilayer aligner material, cutting-edge treatment planning, and advanced aligner features Align Technology, Inc. ("Align") (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced the filing of patent infringement lawsuits against Angelalign Technology, Inc. ("Angel") (Hong Kong Stock Exchange: 6699.HK), a Shangha

    8/18/25 6:00:00 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Technology Announces $200 Million Open Market Repurchase

    Align Technology, Inc. ("Align") (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it is planning to repurchase $200 million of Align's common stock through open market repurchases under Align's $1.0 billion stock repurchase program that was approved by Align's Board of Directors in April 2025. "We are pleased to announce our intention to repurchase $200 million of our common stock through open market transactions. This decision reflects the continued confidence of management and

    8/5/25 8:30:00 AM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Technology President and CEO Joe Hogan Personally Purchases $1 Million of Align's Common Stock

    Align Technology, Inc. ("Align") (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that Joe Hogan, Align Technology president and CEO, has personally purchased approximately $1 million of Align's common stock. Since his last sale of Align common stock in 2021, Mr. Hogan has purchased approximately $8 million of Align common stock1. "This purchase reflects my continuing confidence in the long-term value of Align and our commitment to increasing shareholder value by balancing investment

    8/1/25 6:57:00 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    $ALGN
    Leadership Updates

    Live Leadership Updates

    View All

    Align Technology's Invisalign® Brand Announces Official Sponsorship of Bay FC

    Sponsorship of National Women's Soccer League (NWSL) team highlights inspirational smile stories of women in sports and will help expand access to youth sports across the Bay Area Bay FC, the professional soccer franchise representing the San Francisco Bay Area in the National Women's Soccer League (NWSL), and Align Technology, a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that Align Technology's Invisalign brand is an Official Partner of Bay FC. Through the sponsorship, Bay FC players who are

    3/25/25 4:00:00 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Technology Appoints Emory Wright, EVP Direct Fabrication Manufacturing Platform to Build the Company's Next Generation Manufacturing Operations -- Wright Plans to Retire in 2026

    Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced it has appointed Emory Wright, executive vice president, direct fabrication manufacturing platform, effective immediately. Mr. Wright will transition his current responsibilities for global operations, including treatment planning, and focus on scaling Align's next generation direct fabrication manufacturing platform, working in close collaboration with Srini Kaza, who was promoted to executive vice president, res

    5/22/24 5:00:00 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Technology Appoints Karim Boussebaa, EVP and MD of iTero Scanner and Services Business—Yuval Shaked to Leave Align End of 2023

    Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that after nearly six years with Align, Yuval Shaked, executive vice president and managing director of iTero scanner and services, has decided to leave the company for personal reasons and spend more time with his family. He will remain with Align and continue as a member of Align Technology President and CEO Joe Hogan's staff supporting strategic initiatives and programs through 2023. Mr. Shaked will transition

    2/8/23 4:55:00 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    $ALGN
    Financials

    Live finance-specific insights

    View All

    Align Technology Announces Second Quarter 2025 Financial Results

    Q2'25 total revenues were $1,012.4 million, up 3.4% sequentially and down 1.6% year-over-year Q2'25 total revenues were favorably impacted by foreign exchange by approximately $26.4 million, or 2.7% sequentially, and favorably impacted by approximately $5.6 million, or 0.6% year-over-year(1) Q2'25 Clear Aligner revenues were $804.6 million, up 1.0% sequentially and down 3.3% year-over-year Q2'25 Clear Aligner volume was 644.4 thousand cases, up 0.3% sequentially and year-over-year Q2'25 Imaging Systems and CAD/CAM Services revenues were $207.8 million, up 13.9% sequentially and up 5.6% year-over-year Q2'25 operating income of $163.0 million and operating margin of 16.1%, non

    7/30/25 4:14:00 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Technology to Announce Second Quarter 2025 Results on July 30, 2025

    Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report second quarter 2025 financial results on Wednesday, July 30, 2025, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com. Following the press release, Align will host a conference call to discuss its financial results. The conference call will be

    7/1/25 8:30:00 AM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Technology Announces First Quarter 2025 Financial Results

    Celebrates the 20 million Invisalign® patient "Smilestone" and thanks the more than 280 thousand Invisalign® practitioners around the world for their trust and partnership over the past 28 years Q1'25 Clear Aligner volume of 642.3 thousand cases increased 2.2% sequentially and was up 6.2% year-over-year, reflecting strength in APAC, EMEA, and growth in North America Q1'25 Clear Aligner volume for teens and growing patients of 225.8 thousand increased 4.5% sequentially and 13.3% year-over-year, driven by continued adoption of Invisalign First™ Q1'25 total revenues were $979.3 million, down 1.6% sequentially and down 1.8% year-over-year Q1'25 total revenues were unfavorably impacted by

    4/30/25 4:15:00 PM ET
    $ALGN
    Industrial Specialties
    Health Care